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Human peripheral blood monocytes express plasma membrane receptors for 
fibronectin that is bound to substrates such as denatured collagen, gelatin, and 
fbrin (1). After attachment to surfaces containing fibronectin, monocytes express 
physiological characteristics usually attributed to inflammatory macrophages (2). 
Immune phagocytic activity is  enhanced, as  indicated by increased uptake of 
particles opsonized by IgG and C3 (1) and the engagement of C3 receptors in 
phagocytosis (3). In addition, secretion of neutral proteases such as plasminogen 
activator and elastase after a  phagocytic stimulus is enhanced (4). Fibronectin 
receptors thus appear to be involved in the differentiation of blood monocytes 
into more active, inflammatory cells. In vivo, at a site of injury, these cells would 
be more effective in the clearance of debris and microorganisms in preparation 
for tissue reconstruction. 
We have previously described the basic  features of fibronectin receptors of 
human monocytes (1).  These receptors are present on most, if not all, human 
peripheral blood monocytes (5) and on peritoneal macrophages (6,  7), alveolar 
macrophages (8),  and macrophage cell lines (9).  Receptors can be detected by 
their ability to mediate the attachment of monocytes to fibronectin-containing 
surfaces or by the attachment of fibronectin-coated particles to monocytes (1). 
The interaction of receptor and ligand requires Mg  ++ and is reversed by chelation 
of this divalent cation with EDTA. Both monomeric (190-235  kD) and dimeric 
(450 kD) forms of plasma fibronectin promote monocyte attacfiment to gelatin 
surfaces. Soluble fibronectin, however, interacts poorly with the receptor.  We 
have also found that trypsinization abolishes the ability of monocytes to bind to 
fibronectin-gelatin surfaces,  suggesting that a  protein-containing structure  on 
the cell surface is involved in receptor activity. 
In the present paper we describe a molecule on the surface of  human peripheral 
blood monocytes that appears to be a plasma membrane receptor for fibronectin. 
This protein has been identified by using a  monoclonal antibody, A6F 10,  that 
prevents  the  interaction between  monocytes and substrate-bound fibronectin. 
Thus, at least functionally, the antibody appears to recognize the plasma mem- 
brane  receptor  for  fibronectin.  We  define the  properties  of this  monoclonal 
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antibody  and  report  the  biochemical  characteristics,  distribution,  and  cellular 
specificity of the surface antigen it recognizes. 
Materials and  Methods 
Reagents.  The following materials were obtained from commercial sources: polyeth- 
ylene glycol (J. T. Baker Chemical Co., Phillipsburg, NJ); EDTA and sodium azide (Fisher 
Scientific  Co.,  Pittsburgh,  PA);  protein  A  from Staphylococcus aureus,  gelatin,  bovine 
serum albumin (BSA), ~ apro~inin,  phenylmethylsulfonyl fluoride (PMSF),  polyvinylpyr- 
rolidine, and Ficoll  type 70 (Sigma Chemical Co., St.  Louis, MO); Hypaque-Ficoll (Phar- 
macia,  Inc.,  Piscataway,  NJ);  papain  (Worthington  Biochemical  Corp.,  Freehold,  NJ); 
Enzymobeads (Bio-Rad  Laboratories,  Richmond,  CA);  fetal  calf serum  (FCS)  (Irvine 
Scientific, Santa Ana, CA);  Dulbecco's modified Eagle's medium (DME) (Gibco Labora- 
tories,  Grand  Island,  NY);  mouse  IgG (Miles  Laboratories  Inc.,  Naperville,  IL);  and 
F(ab')2 fragments of goat  antiserum  to  mouse  IgG and  its  fluorescein  isothiocyanate 
(FITC)-conjugated form (Tago, Inc., Burlingame, CA).  Fibronectin was prepared from 
human  plasma  either  by  heparin  precipitation  and  ion  exchange  chromatography, as 
previously described (10, 11), or by affinity chromatography on gelatin-Sepharose columns 
(12). The latter material was obtained from the New York Blood Center Blood Derivatives 
Program.  Both  preparations  were  highly  purified,  as  determined  by sodium  dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 
Preparation  of Human  Peripheral Blood Monocytes.  Mononuclear  cells were obtained 
from peripheral blood of volunteer donors.  The blood was collected in  10 mM EDTA, 
and mononuclear cells were fractionated by density gradient centrifugation in Hypaque- 
Ficoll (13).  The cells were resuspended in DME and washed by centrifugation. Platelets 
were removed by low speed centrifugation. 
Monocytes were purified by adhesion to fibronectin-gelatin-coated plates, as described 
below (monocyte-binding assay);  nonadherent cells were removed by washes with DME, 
and the adherent monocytes released by incubation with 5 mM EDTA. This cell suspension 
was composed almost exclusively (99%) of monocytes, as assessed by nonspecific esterase 
staining (14) and by phagocytic assays using sheep erythrocytes coated with rabbit IgG 
and mouse complement (I 5). 
Preparation  of Neutrophils.  Neutrophils  were  prepared  from human  venous  blood 
anticoagulated with EDTA by density gradient centrifugation in Hypaque-Ficoll, followed 
by dextran sedimentation (16).  Residual erythrocytes were eliminated by hypotonic lysis 
in 0.2% sodium chloride. 
Preparation  of Buffy  Coat Leukocytes.  Whole  blood  was  diluted  1:1  with  phosphate- 
buffered saline (PBS) and centrifuged at 1,800 rpm for 30 min. The leukocyte layer was 
collected and subjected to dextran sedimentation and hypotonic lysis as above. 
Monocyte-bindingAssay.  The binding of monocytes to gelatin-fibronectin-coated plastic 
surfaces was performed as previously described (1).  Briefly, 10-80 #g of purified fibro- 
nectin was added to gelatin-coated wells of 24-well tissue culture plates for 1 h at room 
temperature. After the wells were washed three times with PBS with ions, 106 mononuclear 
cells in 0.5 ml DME with  1% BSA were added to each well and the plates incubated for 
30 rain at room temperature in 5% COz. The wells were washed three times with HBSS 
(Hanks' balanced salt solution with calcium and magnesium ions) to remove nonadherent 
cells,  and  the  monocytes were detached  by addition  of 1 ml  10  mM  EDTA  in  HBSS 
without ions. After  10 rain of gentle agitation at 4°C, released cells were counted in a 
Coulter Counter (model Z; Coulter Electronics, Inc., Hialeah, FL). For inhibition assays, 
cells were preincubated for 30 min at 4°C with the appropriate antibodies, washed once 
by centrifugation, and added to the wells coated with gelatin and fibronectin. 
l Abbreviations used in this paper:  BHK, baby hamster kidney; BSA, bovine serum albumin; DME, 
Dulbecco's modified Eagle's medium; ELISA, enzyme-linked immunosorbent assay; FCS. fetal calf 
serum;  FITC,  fluorescein  isothiocyanate;  HAT,  hypoxanthine,  aminopterin,  thymidine;  HBSS, 
Hanks' balanced salt solution with Ca  ++ and Mg++; HPLC, high performance liquid chromatography; 
NP-40, Nonidet  P-40; PAGE, polyacrylamide gel electrophoresis; PBS; phosphate-buffered  saline; 
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Latex  Bead Binding Assay.  Gelatin-coated  latex  beads  were  prepared  as  previously 
reported  (1). Briefly,  washed  beads  were  suspended  in  PBS  containing heat-liquefied 
gelatin (10 mg/ml) and incubated at room temperature for 2 h. The beads were washed 
four times and resuspended in DME at 3 X 107 beads/ml.  Mononuclear cells (2 x  104) in 
3%  human  serum  were  allowed  to  attach  to  microtiter  wells  at  37°C  for  1 h  in  an 
atmosphere of 5% CO2. Nonadherent cells were removed by washing with DME. Super- 
natant (10 ul)from hybridoma cultures was incubated with the cells for 30 min at room 
temperature. The cells were then washed with DME and incubated with gelatin-fibronec- 
tin-coated latex beads at 37°C for 1 h. The cells were washed with DME and fixed with 
glutaraldehyde before counting of rosettes, defined as more than two beads per monocyte. 
Binding of lgG and Complement-coated Sheep Erythrocytes.  This assay was performed as 
previously described (15). IgG-coated sheep erythrocytes or IgM and complement-coated 
erythrocytes were prepared by standard procedures (15) using mouse serum as a source 
of complement. Indicator erythrocytes were prepared on the day of use and suspended 
at 1 X 108 cells/ml in DME. 
Preparation of Monoclonal Antibodies.  BALB/c mice,  4-6  wk  old,  were  immunized 
according to the following schedule: 7.5 x  106 monocytes were injected intraperitoneally, 
followed by injections of 2.2 x  107 mononuclear cells at 3-wk intervals.  4 d after the final 
injection, the spleen from one animal was removed and teased. Washed spleen cells were 
fused with washed P3U1  mouse myeloma cells at a  5:1  spleen/myeloma cell ratio using 
30% polyethylene glycol (PEG 1000) dissolved in DME (17).  The cells were distributed 
into  96-well  plates  at  2  ×  105  per  well in  DME  with  10%  heat-inactivated  FCS  and 
hypoxanthine, aminopterin, thymidine (HAT) medium (18), and fed every 5 or 6 d. 
Monoclonal antibodies were screened as follows: 96-well plates were coated with gelatin 
and  washed.  Fibronectin  (0.1  ml  of a  50  /~g/ml  solution  in  PBS  with  calcium  and 
magnesium ions) was added to each well and incubated for 1 h at room temperature. The 
plates were washed three times with PBS with ions. Human peripheral blood mononuclear 
cells  (2  x  105) were preincubated with  100 tA of hybridoma supernatant and  50 #1 of 
DME at room temperature for I0 rain in 5% COs. A  100 #1 aliquot of this cell suspension 
was then transferred to the gelatin-fibronectin-coated plate.  The plates were incubated 
for 30 rain  at room temperature in an atmosphere of 5% CO2. Nonadherent cells were 
removed by washing, and adherent cells were fixed with  1.25%  glutaraldehyde in  PBS 
and examined by phase microscopy. Supernatants that inhibited the adherence of mono- 
cytes to the gelatin-fibronectin surface were considered positive. 
Clones were screened for IgG production by immunofluorescence of antibody bound 
to monocytes, using rhodamine-conjugated anti-mouse IgG. Hybridomas were cloned by 
limiting  dilution  and  by  the  soft  agar  technique  according to  a  modification  of the 
procedure of Coffino et al. (19); mouse peritoneal macrophages containing 2.5 x  106 cells 
were  prepared  48  h  in  advance of cloning and  used  as  feeder  layers  for the  cloned 
hybridomas. 
Ascitic fluid containing monoclonal antibodies was prepared by injection of 2-5 x  106 
hybridoma cells  into BALB/c mice primed  1 wk in advance with  0.5  ml of 2,6,10,16- 
tetramethyl-pentadecane.  The ascitic  fluid was tapped every 2 d,  centrifuged at  2,000 
rpm for 10 min, and frozen at -20°C in the presence of aprotinin and sodium azide. 
A6F10 was purified from ascitic  fluid by precipitation with ammonium sulphate (50% 
final concentration) followed by dialysis against 0.02 M Tris buffer, pH 8. This material 
was then chromatographed on DE-52 and the Ig fraction was eluted using a linear gradient 
of 0-200 mM sodium chloride in 0.02 M Tris, pH 8. The antibody was also purified by 
high pressure liquid chromatography (HPLC), using a TSK 3000 column (LKB Instru- 
ments, Inc.), Gaithersburg, MD). Fab fragments of A6F10 were prepared by digestion of 
the purified IgG with a  1:250 (wt/wt) ratio of papain in the presence of cysteine for 22 h 
at  37°C  (20).  Fc fragments and  uncleared  molecules were  removed by ion exchange 
chromatography on DE-52 in  0.02  M Tris-Cl, pH  8.0,  using a  0-300 mM gradient of 
sodium chloride. 
Determination of mouse Ig subclass  was made by radial  immunodiffusion using anti- 
bodies  to  mouse  IgG1,  IgG2a, and  IgG2b.  Quantitation  of IgG1  was  obtained  using 160  MONOCYTE  RECEPTORS  FOR  FIBRONECTIN 
purified standards. Ig concentrations were determined by an enzyme-linked immunosor- 
bent assay (ELISA) (21) using alkaline phosphatase-conjugated rabbit antibodies to mouse 
IgG. 
Indirect Immunofluorescence.  Mononuclear cells (4 X 105) in 100 ~1 of DME containing 
10% human serum were allowed to attach to round (13 mm) glass coverslips  for 30 rain 
at 37°C in 5% CO~. Nonadherent cells were removed by washing with DME.  100 ~1 of 
antibody dilutions were added to the coverslips and incubated in ice for 30 min. Coverslips 
were then  washed  three  times  in  ice-cold DME once in  PBS containing 2%  FCS and 
0.01% sodium azide, and once in  PBS.  FITC-conjugated, affinity-purified F(ab')~  frag- 
ments of goat antibodies to mouse IgG, which had been spun for 30 rain at  15,000 g, 
were added to each coverslip for 30 min. Coverslips were washed twice with PBS, fixed 
with ice-cold  4%  paraformaldehyde in  PBS at pH 7 for 10 min, and then washed twice 
more with PBS. Cells were viewed with a  100x oil immersion lens on a Nikon epifluores- 
cence microscope. 
Flow Cytometry.  Human leukocytes (2 X 10  ~) were incubated for 45 rain at 4°C with 
shaking in  400 #l of DME containing 20 ttg/ml A6FI0 or 50-fold diluted ascitic  fluid. 
The cells were washed twice with PBS containing 2%  FCS and 0.01% sodium azide and 
then resuspended in the above buffer containing a  1:5 dilution of F(ab')~  fragments of 
goat antiserum to mouse IgG that had been absorbed with human red blood cells. After 
a 45 min incubation at 4°C with shaking, the cells were washed twice and resuspended in 
1 ml of the above buffer. Fluorescence was analyzed in a FACS IV flow cytometer (Becton 
Dickinson Immunocytometry, Mountain View,  CA) at a  gain of 8,  laser power of 300 
roW, and photomultiplier tube voltage of 860 V. 
SDS-PACE.  Cells were lysed in 0.5%  Nonidet-40 (NP-40) in the presence of PMSF 
and aprotinin. Nuclei were removed by centrifugation. Samples  were electrophoresed on 
discontinuous pH, 5-15% polyacrylamide gradient slab gels (22). 
Electrophoretic  Transfer  of  Proteins from  SDS-Polyacrylamide Gels  to  Nitrocellulose 
Sheets.  Western blots were prepared according to previously described procedures (23, 
24).  Electrophoretic transfer was performed at 300 mA for 4 h at 4°C.  Nitrocellulose 
sheets were soaked overnight in  10 mM Tris, pH 7.4, 2 mM EDTA, 2% BSA, 2% Ficoll 
type 70, and 2% polyvinylpyrrolidine (40T), and then washed three times for 1 h in PBS. 
A6F 10 ascites fluid diluted 1:20 in washing solution (10 mM Tris, pH 7.4, 0.14 M NaCI, 
0.5% BSA, 2 mM EDTA, and 0.25% NP-40) was incubated with the electroblots for 4 h. 
Electroblots were washed three times for 30 rain and once overnight. F(ab')2 fragments 
of a goat antiserum to mouse IgG, iodinated using Enzymobeads (Bio-Rad Laboratories), 
were added to the strips at 105 cpm/cm  2 and incubated for 3 h. The strips  were washed 
extensively, dried at room temperature, and exposed to x ray film. 
Isoelectric Focusing.  Isoelectric focusing was performed on 1 mm polyacrylamide gels 
using ampholines in the pH range 3.5-9.5 (25). 
Results 
Monoclonal Antibody A6FIO.  Two separate  fusions of spleen cells from mice 
immunized with  human peripheral  blood monocytes yielded  two clones which 
produced  antibodies  that  inhibited  the  binding  of monocytes  to  fibronectin- 
gelatin surfaces; one of these,  A6F10, was stable.  A6F10 was recloned twice by 
limiting  dilution  and  once  in  soft  agar.  In  the  latter  procedure,  clones  were 
selected  both  for  the  inhibition  of monocyte binding  to  fibronectin  and  for 
increased IgG production. 
Biochemical  Characteristics  of A6FIO.  A6F10  was  purified  by several  proce- 
dures (see Materials and Methods). The antibody elutes from DEAE cellulose at 
a conductivity of 4.3 mS. In both immunoelectrophoresis and radial immunodifo 
fusion  assays,  A6F10  was  shown  to  bear  determinants  of IgG1  mouse  Ig.  In HOSEIN  AND  BIANCO  161 
isoelectric  focusing, A6F10 showed a pI of 6.6 (Fig.  1). A6F10 does not bind to 
protein A-Sepharose columns of pH 7.0-8.2. 
Inhibition of Monocyte Attachment.  All  clones  and  subciones  derived  from 
A6F 10 were tested for the ability to inhibit binding of monocytes to plates coated 
with  gelatin  and  fibronectin.  The  inhibition  of binding  was dependent  on  the 
concentration  of IgG  (Fig.  2).  Maximal inhibition  occurred  at ~1  ~g IgGl/ml. 
Equivalent concentrations  of ascitic  fluid  from mice producing  irrelevant  anti- 
bodies had no effect. 
Fab fragments prepared  from purified  A6F 10  IgG were also effective  inhibi- 
tors of monocyte attachment.  In the experiment  depicted  in Fig.  3, the gelatin 
surface was preincubated with various amounts of fibronectin.  Complete inhibi- 
tion of monocyte binding was observed at all concentrations,  indicating that the 
Fab fragments of the antibody were effective  even when many fibronectin  sites 
were available for cell attachment. This experiment also indicated that the activity 
FIGURE  1.  Isoelectric focusing of the monoclonal antibody A6F10. A6F10 IgG was analyzed 
by isoelectric focusing.  The pH gradient determined by surface electrode is indicated at right. 
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FIGURE 2.  The  monoclonal  antibody  A6F10  inhibits monocyte  attachment  to fibronectin- 
gelatin surfaces.  Human peripheral blood monocytes were incubated with increasing amounts 
of A6F10  antibody  for  30  min  at  4°C.  Cells  were  then  centrifuged,  resuspended  in  DME, 
added to fibronectin-gelatin  plates, and  incubated for 30  min at room  temperature.  Nonad- 
herent cells  were  removed  by  washing,  and  adherent  cells were  detached  with  EDTA  and 
counted. The dotted line represents the activity of a monoclonal antibody of the IgG 1 subclass 
of undetermined  specificity. Vertical bars represent ±SEM. 162  MONOCYTE  RECEPTORS  FOR  FIBRONECTIN 
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FIGURE  3.  Fab fragments of the monoclonal antibody A6F10 inhibit monocyte attachment 
to gelatin surfaces containing fibronectin. Human peripheral blood monocytes were preincu- 
bated with 37 #g of Fab of A6F10 as in Fig.  1. The cells were then plated on gelatin surfaces 
containing varying amounts of fibronectin. The number of adherent cells was determined as 
in Fig.  1. Vertical bars represent _+SEM. 
of A6F10  is  related  to  its  antibody  specificity and  not  simply  to  interactions 
mediated by the  Fc portion  of the  molecule.  A6F10 also completely inhibited 
the attachment  of gelatin-fibronectin-coated  latex  beads to monocytes (results 
not shown). 
Other Properties  of A6FlO.  Neither  A6F10  nor  its  Fab  fragments  had  any 
effect on the attachment of human peripheral blood monocytes to plastic or glass 
surfaces, on rosette formation between monocytes and sheep erythrocytes coated 
with IgG and/or C3, or on the phagocytic uptake by monocytes of these opsonized 
erythrocytes or of 1.1-~m latex beads. These experiments indicated that A6F 10 
does not react with monocyte receptors for Fc of IgG, with receptors for C3, or 
with the  nonspecific receptors involved in phagocytosis of latex beads.  A6F10 
was not  toxic  to  monocytes in  culture  for periods up  to  1 h  at  37°C.  In  the 
presence of rabbit complement, A6F 10 was unable to mediate lysis of monocytes, 
as assessed by trypan blue exclusion. 
A6FI0 did not react in Ouchterlony assays or in ELISA with  human  serum 
proteins,  purified  fibrinogen,  or  purified  fibronectin.  Monoclonal  antibodies 
directed  against  fibrinogen  and  fibronectin  were  used  as  positive  controls  in 
these experiments. 
Binding of A6FlO to Blood Cells.  Fluorescence microscopy revealed that both 
A6F10  IgG and  its Fab fragments  bound only to peripheral  blood monocytes. 
Intracellular  staining  was never  observed.  When  these  experiments  were per- 
formed at 4°C in the presence of sodium azide, fluorescence appeared as a ring 
of small patches in the external circumference of the cells (Fig.  4).  Staining  of 
lymphocytes, neutrophils, platelets, or erythrocytes was not observed in fluores- 
cence microscopy. A6F 10 did not stain human dendritic cells (personal commu- 
nication, R. Steinman, The Rockefeller University, New York). A6F10 did stain HOSEIN  AND  BIANCO  163 
FIcuaE 4.  Indirect  immunofluorescence staining of human peripheral blood monocytes 
coated with  the monoclonal  antibody A6F 10. Human peripheral blood monocytes  purified by 
Hypaque-Ficoll  and adherence to glass coverslips were incubated with A6F 10 ascites, followed 
by FITC-conjugated F(ab')2 fragments of a goat antiserum to mouse IgG, as described in 
Materials and Methods. (a) Fluorescence micrograph. (b) Phase contrast micrograph of the 
same field. × 1,000. 
tissue sections of human tissue macrophages, human alveolar macrophages, and 
guinea  pig  macrophages  (personal  communication,  R.  Colvin,  Massachusetts 
General Hospital, Boston). 
When  buffy coat  leukocytes treated  with  A6F10  or its  Fab  fragments were 
analyzed by FACS, several observations were made. A majority of cells (85%) in 
the monocyte population, defined by its light-scattering properties, were intensely 
stained (Fig. 5a).  In contrast to the microscopic methods used above, the more 
sensitive FACS technique revealed that neutrophils also bound A6F10, but at a 
level  fourfold  less  than  found  on  monocytes  (Fig.  5b).  A6F10  did  not  stain 
lymphocytes (Fig. 5c). 
Cellular  Specificity of A6FIO.  Since  fibroblasts  have  been  shown  to  carry 
plasma  membrane  receptors  for  fibronectin  (26),  we  assessed  the  binding  of 
A6F 10 to two fibroblast cell lines (MRC-5 and FL-2000; Flow Laboratories, Inc., 
McLean,  VA)  and  to  primary  human  foreskin  fibroblasts  using  fluorescence 
microscopic  methods.  Fluorescent  staining  was  not  observed  in  any  of these 
cases. 
A6F10 does not react with human umbilical cord endothelial cells in culture 
(personal  communication,  M.  Bevilacqua,  Harvard  University,  Brigham  and 
Woman's Hospital, Boston). A6F10  reacts with guinea pig monocytes and mac- 
rophages but not with rat monocytes, mouse peritoneal macrophages,  hamster 
monocytes, or the mouse macrophage cell line J774. 
Cell Surface Antigen  Recognized by A6FIO.  To identify the molecular species 
recognized by monoclonal antibody A6F10,  N P-40  detergent lysates of human 
mononuclear cells were subjected to electrophoresis in SDS-PAGE, transferred 
to nitrocellulose filters by electroblotting, and incubated with A6F10 antibody 164  MONOCYTE  RECEPTORS  FOR  F1BRONECTIN 
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FLUORESCENCE  INTENSITY 
FICURE 5.  FAGS analysis of A6F10 staining of blood leukocytes. A buffy coat preparation 
of human peripheral blood leukocytes was incubated with A6F 10 ascitic fluid and stained with 
FITC-conjugated F(ab')e fragments of a goat antiserum to mouse IgG. Cell populations were 
analyzed by forward and right angle light scattering, and monocytes, neutrophils, and lympho- 
cytes were gated for separate fluorescence analysis.  Solid lines represent fluorescence intensity 
distribution of stained cells.  Broken lines represent control cell preparations in which A6F10 
was  omitted.  (a)  Monocyte  gated distribution.  (b)  Neutrophil  distribution.  (c)  Lymphocyte 
distribution. 
and then with F(ab')2 fragments of a goat anti-mouse IgG labeled with ]25I.  Fig. 
6  shows that  A6F10  specifically bound a  protein  with  an  apparent  molecular 
weight of 110,000 (110 K).  Ascitic fluid of mice bearing irrelevant  hybridomas 
did  not  stain  bands  in  this  area  of the  gel  (Fig.  6).  The  110  K  tool  wt  band 
showed the same mobility in reduced and nonreduced gels, indicating that  it is 
made of a single polypeptide chain (Fig. 7). 
The  band observed with  mononuclear  leukocytes was also seen with human 
peripheral  blood monocytes isolated by adherence to a plastic surface.  Purified 
A6F 10 IgG, as well as ascitic fluid from mice bearing five different subclones of 
A6F 10, reacted with a species of the same apparent molecular weight. No reactive 
bands were observed in lysates of human erythrocytes, lymphocytes, or platelets. 
Protease Susceptibility of the Antigen  Recognized by Monoclonal Antibody A6FIO. 
The interaction  of monocytes with surfaces or particles coated with gelatin and 
fibronectin is abolished by pretreatment of the monocytes with trypsin (1). Thus, HOSEIN  AND  BIANCO  165 
FIGURE 6.  Western blot analysis of detergent lysates of human mononuclear leukocytes. The 
antigen to which the A6F 10 antibody bound was determined by Western blot analysis.  Lysate 
from 107 cells solubilized in 0.5% NP-40 was applied to each lane. (1) Coomassie Blue-stained 
gel of cell lysate.  (2)  Autoradiogram  of Western  blot  with  A6F10.  (3)  Autoradiogram  of 
Western blot with irrelevant ascites. The positions of the standard  proteins used to calibrate 
the gel are shown at right. 
FIGURE 7.  Western blot analysis of A6FI0 reaction with reduced and nonreduced lysates of 
human  mononuclear cells.  Electroblots were prepared as in  Fig. 6  (1)  Reduced. (2)  Nonre- 
duced. 
it was of interest  to examine  the susceptibility of A6F10 antigen  to proteases. 
The  110  K  tool  wt antigen  was  resistant  to  endogenous  proteases  commonly 
present in cell preparations.  Incubation of cells at 37 °C in the absence of protease 
inhibitors for periods up to 60 min resulted in no decrease in the intensity of the 
110  K band detected with A6F10 in Western blot analysis (Fig.  8, lanes  I  and 
2). The antigen recognized by A6F10 was, however, susceptible to digestion by 
trypsin.  Treatment  of cells with 250 #g trypsin resulted in complete loss of the 
110 K mol wt band within  15 min of incubation at room temperature, conditions 
similar to those that abolish monocyte flbronectin receptor activity (Fig. 8, lanes 
3-5). No lower molecular weight fragments reactive with A6F 10 were observed. 
Similar results were observed using indirect immunofluorescence. Mononuclear 
cells attached  to  coverslips and  incubated  with  200  #g  trypsin  for  25  rain  at 
37°C,  followed by  200  #g  trypsin  inhibitor,  showed  substantial  reduction  of 
fluorescence staining by A6F10 compared with untreated controls. The proteo- 
lytic  action  of trypsin  was  confirmed  by  monitoring  the  loss  of C3  receptor 
activity  using  the  sheep  erythrocyte  rosette  assay  on  coverslips  prepared  in 
parallel. 
Discussion 
Several lines of evidence indicate that monoclonal antibody A6F10 appears to 
recognize the plasma membrane receptor for fibronectin or a  closely associated 166  MONOCYTE  RECEPTORS  FOR  FIBRONECTIN 
FIGURE 8.  Proteolytic susceptibility of 110 K  mol wt antigen. (1 and 2) Mononuclear cells 
(7.5 x  106) were incubated at 37 °C in the absence of protease inhibitors for 0 (1) and 60 min 
(2) before NP-40 lysis and Western blot analysis with A6F10. (3, 4, and 5) Mononuclear cells 
(7.5 X  106) from the same preparation were incubated in DME containing 250 ~g trypsin at 
room temperature for 15 (3), 30 (4), or 60 min (5). The reaction was terminated by addition 
of 250 ~g soybean trypsin inhibitor. Cells were then washed, lysed with NP-40, and subjected 
to Western blot analysis with A6F10. 
membrane structure of human peripheral blood monocytes. First, the fibronec- 
tin-mediated  attachment  of monocytes  to  gelatin-coated  surfaces,  which  we 
previously described (1),  is inhibited by A6F10.  Fab fragments of the antibody 
retain this property, ruling out a possible interaction of A6F10 with membrane 
receptors for the Fc fragment of IgG, and indicating that the specificity is related 
to  the  antibody-combining  region  of the  molecule.  A6F10  also  inhibits  the 
binding of latex beads coated with gelatin and fibronectin to human peripheral 
blood monocytes. Monoclonal antibodies with undetermined specificities did not 
express this activity. 
A6F 10 did not interfere with other known receptors on the monocyte surface, 
particularly the receptors for Fc of IgG and for C3, in that it did not interfere 
with the attachment or phagocytosis of erythrocytes coated with these ligands. 
Also,  the  molecular species  identified  by  A6F10  migrates  with  an  apparent 
molecular weight of 110  K, different from those reported for the Fc receptor 
on  neutrophils and  monocytes (51-73  K)  (27,  28)  and  for C3b  receptors on 
monocytes and erythrocytes (205 K) (29, 30). The C3bi receptor consists of two 
polypeptide chains of 185 and  105  K mol wt (31). The smaller chain cannot be 
easily distinguished from the 110 K species we have obtained for the fibronectin 
receptor. In Western blot experiments (not shown) using monoclonal antibodies 
against the Fc receptor (3G8, kindly provided by Dr.J. Unkeless, The Rockefeller 
University) and to the C3b receptor (57F,  kindly provided by V.  Nussenzweig, 
New York University), both bands were clearly distinct from the 110  K mol wt 
fibronectin receptor. 
The cellular distribution of the antigen recognized by A6F 10 is also compatible 
with the cellular distribution of the flbronectin receptor on blood leukocytes. In 
immunofluorescence assays, the majority of peripheral blood monocytes stained 
intensely with A6F 10.  Neutrophils showed a low degree of fluorescence, detect- 
able only by FACS  analysis.  Erythrocytes and  lymphocytes did  not stain  with 
A6F10.  The receptor for fibronectin has been previously recognized on mono- HOSEIN AND  BIANCO  167 
cytes  (1)  and  on  neutrophils  (32),  and  was  not  detected  on  erythrocytes  or 
lymphocytes. 
The protease sensitivity of the antigen recognized by A6F10 was also similar 
to that of the fibronectin receptor of monocytes. Trypsin  treatment prevented 
monocyte attachment  to fibronectin-gelatin  surfaces and destroyed the antigen 
recognized  by A6F10  in  Western  blots.  Finally,  the  cell  line  U937  could  be 
induced  to  express  increased  attachment  to  fibronectin-gelatin  surfaces  when 
exposed  to  gamma  interferon.  This  is  paralleled  by  increased  expression  of 
A6F10  antigen  on  the  cell  surface, 2 again  supporting  the  association  of the 
antigen  recognized by A6F10  with the functionally recognized  fibronectin  re- 
ceptors of monocytes. Proof of the specifcity of the monoclonal antibody A6F 10 
will depend on the isolation of the plasma membrane antigen  and the demon- 
stration  of its  ability  to  specifically  recognize  fibronectin-gelatin  surfaces and 
compete with monocytes in their attachment to these surfaces. These experiments 
are currently in progress. 
The  differences in  intensity  of staining  between monocytes and  neutrophils 
deserve special consideration. Neutropbils expressed at least fourfold less A6F ! 0 
antigen  than  monocytes.  Also,  a  population  of ~15%  monocytes showed  the 
same staining intensity as neutrophils. In five experiments, FACS analysis showed 
that 72-96% (~ =  85%) of monocytes possess detectable A6F10 antigen.  In the 
cell attachment  assays, -85%  of the peripheral  blood monocytes bound effec- 
tively  to  plates  coated  with  gelatin  and  40  t~g/cm  2 fibronectin  (unpublished 
observation). 20 % of the circulating monocytes identified by nonspecific esterase 
staining were unable to attach to these surfaces. On the other hand, neutrophils 
do not attach to fibronectin-gelatin surfaces (1). These observations suggest that 
20%  of the  monocytes and  100%  of the  neutrophils  in circulation  have fewer 
fibronectin  receptors  than  required  for  effective  attachment  to  fibronectin- 
coated surfaces.  In essence, fibronectin receptors seem to mediate at least two 
different functions:  they induce functional  responses such as the expression of 
increased Fc and C3 receptor activity, and mediate attachment of monocytes to 
surfaces containing fibronectin, expressed only by those monocytes with a higher 
density of plasma membrane receptors. 
Cells other  than  monocytes, most  notably fibroblasts, bind  fibronectin  (26). 
Our  finding that  the A6F10  monoclonal antibody does not bind to fibroblasts 
indicates  that  the  monocyte receptor  contains  antigenic  determinants  distinct 
from  those of fibroblast receptors for fibronectin.  Other  differences between 
monocyte  and  fibroblast  receptors  have  been  recognized:  monocytes,  unlike 
fibroblasts, do not synthesize fibronectin and do not contain fibronectin on their 
surfaces. Fibronectin is detected on macrophages only during long-term culture 
(33).  Fibroblasts,  on  the  other  hand,  contain  fibronectin  in  their  pericellular 
matrix (34). The receptors of monocytes and fibroblasts have different protease 
sensitivity profiles and  Mg  ++ requirements.  The monocyte fibronectin receptor 
is trypsin sensitive and requires Mg  ÷+ for its activity (1), whereas the fibroblast 
receptor is not trypsin sensitive (35) and does not require Mg  ++ for binding (26). 
However,  these  differences  do  not  preclude  the  existence  of structural  and 
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functional similarities between fibronectin receptors of fibroblasts and macro- 
phages. 
The  110  K  mol  wt  surface protein  to  which  A6F10  binds  is  substantially 
smaller in molecular weight than the 140 K fibronectin receptor recently isolated 
from a  fibroblast cell line (36).  However, antibodies that block the binding of 
fibroblasts to fibronectin-coated surfaces immunoprecipitate a complex of pro- 
teins of 160-95 K tool wt, of which the 140 K receptor appears to be a member. 
It is possible  that the  110  K mol wt protein of monocytes may associate with 
proteins analogous to the  140 K species.  A smaller fibroblast surface protein of 
48-49 K mol wt has also been proposed as the fibroblast fibronectin receptor. It 
can be crosslinked to substrate-bound fibronectin (37) and has been proposed to 
be  involved  in  cell  adhesion  to  fibronectin,  based  on  its  calcium-dependent 
stability to trypsin and its binding to wheat germ agglutinin (35).  Pytela et al. 
(36)  have  suggested  that  this  protein  may  be  involved  in  the  assembly  of 
fibronectin into matrix (38) whereas the 140 K mol wt protein is involved in cell 
attachment. 
Because of its specificity for mononuclear phagocytes, the monoclonal antibody 
A6F10 provides a specifc probe for cells of monocyte lineage in tissues in vitro, 
and in marrow populations. It may also prove to be a valuable tool in assessing 
the role of fibronectin in monocyte function. 
Summary 
We describe a molecule on the surface of human peripheral blood monocytes 
that  appears  to  be  a  plasma  membrane  receptor  for  fibronectin.  We  have 
identified this protein using a monoclonal antibody, A6F 10, which prevents the 
interaction between monocytes and substrate-bound fibronectin. Thus, at least 
functionally, the antibody appears to recognize the plasma membrane receptor 
for fibronectin. The antibody and its Fab fragments bound to the cell surfaces 
of human monocytes, tissue macrophages, and, to a lesser extent, neutrophils. It 
did not react with fibroblasts, lymphocytes, platelets, or erythrocytes. It bound 
human and guinea pig cells but did not react with rat, mouse, or hamster cells. 
In Western blots, this monoclonal antibody bound specifically to a polypeptide 
with apparent molecular weight of 110,000  and made of a  single chain. The 
antigen recognized by A6F 10 was susceptible to trypsin digestion. These obser- 
vations suggest that the monoclonal antibody A6F 10 is directed to the fibronectin 
receptor of human monocytes. 
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